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http://www.biomedcentral.com/1471-2261/14/164RESEARCH ARTICLE Open AccessA new method of building permanent A-V block
model: ablating his-bundle potential through
femoral artery with pre-implanted biventricular
pacemaker
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Background: To explore the feasibility of a new method of achieving a permanent A-V block animal model.
Methods: 16 beagles were randomly divided into two groups based on the method of their pre-implanted biventricular
pacemakers. (1) In the first group (8 beagles), the A-V block model was achieved by ablating his-bundle potential at the
site of the left ventricular superior-septum, under the aortic sinus, through femoral artery. (2) In the second group
(8 beagles), the A-V block model was achieved by ablating his-bundle potential at the triangle of Koch, through
femoral vein. A complete A-V block model was achieved as a standard in this study. The success rates, intraoperative
arrhythmias, operative and X-ray exposure time, intraoperative bleeding amount were assessed in this two groups, both
animal models were followed up for four weeks and then fasted to monitor myocardial pathological changes.
Results: The success rate of the first group, which with fewer intraoperative arrhythmias, and less operative and X-ray
exposure time, was significantly higher than the second group.
Conclusions: Compared with traditional animal method, our new method of ablating his-bundle potential at the left
ventricle from the femoral artery has a higher success rate, fewer occurrence of malignant arrhythmias, and less operation
and X-ray time. Thus, our new method should be preferred in the building of Permanent A-V Block Model.
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Arrhythmias are usually classified as tachyarrhythmias
or bradyarrhythmias. A complete A-V block is a severe
kind of bradyarrhythmia, the causes of pathological A-V
block are varied and include ischaemia, infarction, fibro-
sis or drugs. Patients with complete heart block are fre-
quently hemodynamically unstable, and as a result, they
may experience hypotension, syncope, cardiovascular col-
lapse, malignant arrhythmias, or even death. The cause of
death may often be tachyarrhythmias precipitated by pro-
longation of ventricular repolarization secondary to the
abrupt changes in rate. Unless the heart block is due to a
medication that can be discontinued or an infectious* Correspondence: linjiafeng_wzmcfey@163.com
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unless otherwise stated.process that can be effectively treated, most patients with
acquired complete heart block should receive a permanent
pacemaker. When treated with permanent pacing, the
prognosis is better. So far, the implantation of a pace-
maker is generally accepted as a main therapy for this
disease in clinic.
To fully understand the pathogenesis of the complete
A-V block and to evaluate the therapeutic effects of dif-
ferent interventions for this kind of disease,a convenient,
simple, and reliable animal model is needed. Currently,
the ablation of his-bundle potential at right ventricular
Koch triangles via the femoral vein is widely used for a
complete A-V block, but it still has inherent disadvan-
tages such as difficulty in mapping his-bundle potential,
no response to his-bundle potential ablation and easily
triggered ventricular arrhythmias. Based on the improve-
ments of the traditional method, here we described aLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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vantages, in which we ablated his-bundle potential under
the aortic valve in the left superior ventricular septum
from the femoral artery to build a complete A-V model.
PREVENT-HF German Substudy has demonstrated a
significant advantage of biventricular pacing vs right
ventricular pacing for atrioventricular block in terms of
spiroergometric exercise capacity in patients without
previous advanced heart failure after 1 year [1]. So in
our study, we chose biventricular pacing prior to right




A total of sixteen healthy beagles, male, 2-year-old,
weight(18.76 ± 1.72)kg, were obtained from Nanjing
Yadong Laboratory Animal Research Center [SCXK(S)
2011.0013]. All 16 beagles were housed in the laboratory
animal center of Wenzhou Medical University. All ex-
periments were carried out in accordance with the
China Animal Welfare Legislation and were approved by
the Wenzhou Medical University Committee on Ethics
in the Care and Use of Laboratory Animals.
Preoperative preparation
Before operation, beagles were fasted of food for 12 hours
and water for 4 hours. The chest, back, and side-limbs’
skin was shaved, washed, and sterilized. Half an hour
after intraperitoneal injection of 3% pentobarbital so-
dium (30 ml/kg) (Xitang Biological), subjects got general
anesthesia.
Implantation of biventricular synchronization pacemaker
After anesthesia, beagles were fixed onto the operation
table in the supine position, with back paddle (indifferent
electrode) placed over the left scapula. After endotracheal
intubation, the beagles were ventilated by means of a res-
pirator (SIMV mode, respiration rate 20 bpm, tidal vol-
umn 10-20 ml/kg, oxygen flow 4-6 L/min, fraction of
inspired oxygen 40%-60%) during the operation time, and
repeated doses of pentobarbital sodium were infused as
necessary throughout the experiment. The Electrocardio-
grams were continuously recorded throughout the oper-
ation. Medtronic CapSureFix Novus(TM)5076 Leads were
inserted from subclavian vein, went through the superior
vena cava, right atrium, and fixed into the apex of the right
ventricle. Three pacing parameters of leads were moni-
tored – the pacing threshold, pacing impedance and R-
wave amplitude, for required ventricular pacing threshold
(<1.0 V), required R wave amplitude (>5.0 mV), and ven-
tricular pacing impedance in the range from 400 to
1000Ω. The thoracic cavity was opened along the left fifth
intercostal space, and the pericardium was opened to fixthe Medtronic Capsure Epi4965 leads onto the avascular
area of the lateral left ventricular wall before closure of the
cavity. A subcutaneous tunnel was made to lay the right
ventricle’s endocardial lead from the cervical region to the
thoracic region. The endocardial lead and epicardial lead
were linked to a biventricular pacemaker, which was put
into a pre-made subcutaneous sac on the thoracic region.
The function of the pacemaker was tested, and pacing pa-
rameters were set with VVI pacing mode and pacing fre-
quency, which had 10 ~ 20 beats every minute more than
the subject its own. After confirmation the proper condi-
tions for the pacemaker,we sutured the subcutaneous tis-
sue and skin.
Ablation of his-bundle potential after implantation of
biventricular synchronization pacemaker
After successful implantation of biventricular syn-
chronization pacemakers in the subjects, pacemakers
working in VVI mode were established and the VVI
pacing frequency was reinstalled to 60 bpm. Next, sub-
jects implanted with biventricular pacemakers were ran-
domly divided into two groups: (1)The first group:
Ablation of his-bundle potential in left ventricle (n = 8),
weight(18.89 ± 1.56)kg. (2). The second group: Ablation
of his-bundle potential in right ventricle(n = 8), weight
(18.64 ± 1.40)kg.
In the first group, a 7 F arterial sheath was placed in
the femoral artery using Seldinger ’s method, and a 7 F
temperature-controlled ablation catheter (Biosence
Webster, USA) was delivered to the root of aorta via the
arterial sheath in the guidance of X-ray. If the his-
bundle potential was found while searching in the non-
coronary cusp, we tried to ablate it. If not, the catheter
was delivered across aortic valves and into left ventricle.
We usually found the biggest his-bundle potential in
the area of left ventricular superior septum, near the
root of aorta. In addition, if a fixed relationship between
A, H, and V potential existed, we tried to ablate it with
a temperature of 60°C, energy of 60w, and the imped-
ance varies between 80Ω-150Ω. If the complete A-V
block appeared with a consistent VVI pacing rhythm
during a 10s discharge, the potential was considered an
effective ablation target and received another 60s dis-
charge. If the complete A-V block did not appear in
during 10s of ablation, his-bundle potential was reas-
sessed until the effective target potential was found and
the A-V conduction was blocked completely. Success
(complete AV block) was defined under the criteria that
the A-V conduction did not recover, and VVI pacing
rhythm consistently existed after close observation of
the animals for 30 minutes post-operation. We defined
the occurrence of sustained ventricular tachycardia or
ventricular fibrillation as endpoint of operation. If these
arrhythmias happened, then the operation need to be
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the total number of attempts to calculate success rate.
The second group received ablation of his-bundle poten-
tial in the right ventricle. A 7 F vein sheath was placed in
femoral vein using Seldinger ’s method. A 7 F temperature-
controlled ablation catheter (Biosence Webster, USA) was
delivered to the right ventricle through the vein sheath via
X-ray guidance. If a his-bundle potential containing a fixed
relationship with A and V potential was found when
searching in Koch triangles (in the right ventricular upper
septum near tricuspid annulus), discharge was attempted
(the temperature, energy and impedance of ablation were
the same as those of the left ventricle ablation group, and
the ablation success criteria and ablation endpoint were
similar to the left ventricle ablation group).
All subjects whom received operations were intraven-
ously injected with 2000 μl of heparin to prevent blood
clotting during operation(if the operation time was lon-
ger than one hour,additional 500 μl of heparin was
added every hour). After ablation, the arterial or venous
sheaths were removed, we pressed the points closer to
the heart than the sites of puncture to stop bleeding, the
blood from the puncture sites were suctioned and col-
lected into a sterile empty vial to calculate the bleeding
amount. Operation time was recorded from insertion of
sheath to remove of sheaths. All procedures followed
principles of aseptic technique. After operation, the
biventricular pacemaker pacing frequency was repro-
grammed to 130 bpm and the left ventricle pacing was
set 10 ms earlier than the right ventricle. Every dog was
intramuscularly injected with 1.6 million U/day of peni-
cillin for 3 days to prevent infection. The body surface
electrocardiograms (ECG) of subjects were recorded at
least once a week.
Follow-up post-operation
Dogs were followed up with for 4 weeks after operation.
Echocardiographs, ECGs, and plasma BNP concentra-
tions were examined at the time of pre-operation, two
weeks post-operation, and four weeks post-operation re-
spectively. The plasma BNP level was detected by the
quantitative sandwich enzyme immunoassay technique
using the BNP elisa kit (MyBioSource MBS922862).
Echographs were recorded by ultra-sound machine (Philips
CX-30 untra-sound machine). Echocardiograph measure-
ments included:1eft ventricle end diastolic diameter
(LVEDD), 1eft ventricle end systolic diameter (LVESD), in-
traventricular septum diastolic diameter (IVSDD), intraven-
tricular septum systolic diameter (IVSSD), 1eft ventricle
ejection fraction (LVEF),fractional shortening (FS) and 1eft
atrial internal diameter (LAID), all the datas were measured
on parasternal long axis view, the value of LVEF was calcu-
lated by M-mode LV dimensional method. ECGs were re-
corded by ECG machine (Edan SE-1200 express ECGmachine). ECGs measurements included: QRS duration,
QT interval, Tp-Te interval. Subjects were euthanized four
weeks after operation, and the pathological changes of
hearts were observed.
Pathological examination
Ablated myocardial tissue area of the two groups were
collected and every specimen were divided into two
parts. One part was subjected to formalin fixation, alco-
holic dehydration, paraffin embedding, slicing, HE stain-
ing, and ultimately used for pathological study. The other
part of the tissue was preserved in 4% glutaral, washed
with a phosphate buffer, stained with phosphotungstic
acid, embedded in Ciba 5o2 with polymerization, cut with
a Porter-Blum ultramicrotome, stained with toluidine
blue, and ultimately used for ultrastructural study.
Statistics analysis
Data were presented as Mean ± Standard deviation
(x ± s). Independent samples were applied for compari-
son among groups using the t-test and ANOVA ana-
lysis. Enumeration data is described as case numbers
and percentages. The probability was directly measured
among groups through X-squared tests or Fisher’s exact
test. Analysis was performed with SPSS 19.0 statistical
software. A P value of <0.05 was considered as statistically
significant.
Results
The building of a complete A-V block model
All the subjects were successfully implanted with pace-
makers (Figure 1A). Before the ablation of his-bundle
potential, the average heart rate of subjects was 138 ±
9 bpm of sinus rhythm when pacing frequency of pace-
maker was installed at 60 bpm. After ablation of his-
bundle potential, all pacemakers were in good condition
and programmed with a pacing frequency of 130 bpm in
VVI mode. Among the 16 subjects, we achieved complete
A-V blocks in 14 using the two different ablation methods.
The operation time, X-ray exposure time, and amount of
bleeding in the two groups were shown in Table 1. (1) In
the first group, all the subjects survived after operation.
We found an obvious his-bundle potential in the non-
coronary cusp in one dog (Figure 2G), but failed to ablate
it at this site. The his-bundle potentials in 8 subjects were
finally ablated in the area of the left ventricular superior
septum under aortic valve near the non-coronary cusp. In
this group,we achieved complete A-V block in all subjects
without malignant ventricular arrhythmias happened dur-
ing operation. After ablation of his-bundle potential, sub-
ject heart rate was sustained at 130 bpm (VVI pacing
rhythm). (2)In the second group, ventricular fibrillation
occurred in two subjects when ablating his-bundle at
Koch triangles. Despite our best efforts, one subject still
Figure 1 Pacemaker implantation and His-bundle ablation. A. Implantation with biventricular pacemaker; B. In the position of right anterior
oblique (RAO), ablating his-bundle in the left ventricle; C. Ablating his-bundle in the right ventricle; D. Heart specimen from the first group, the
arrow indicates the ablation location; E. Heart specimen from the second group, the arrow indicates the ablation location. ORCA: ostium of right
coronary artery, RV: right ventricle, LV: left ventricle.
Table 1 Comparison of the two groups during operation
Left ventricle ablation group (n = 8) Right ventricle ablation group (n = 8)
Puncture site Right femoral artery Right femoral vein
Ablation site Left ventricular upper septum under aorta ostium Right ventricular Koch triangles
Success case 8(100.00%) 6(75.00%)
Operation time (min) 107.55 ± 13.26 151.74 ± 18.32*
X-ray exposure time (min) 10.22 ± 3.67 15.25 ± 3.70*
Amount of bleeding (ml) 33.31 ± 4.30 9.52 ± 1.28*
Cases of malignant ventricular arrhythmias 0 2
Comparison of the right ventricular ablation group with the left ventricular ablation group, *P < 0.05.
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Figure 2 Electrocardiographs and electrophysiological findings
during the proceduces. A. Electrocardiograph before operation
(in lead III, paper speed was 50 mm/sec); B. Obvious His-bundle
potential at the site of left ventricular upper septum under aortic
sinus (paper speed was 150 mm/sec); C. His-bundle potential in the
right ventricle was much smaller than that in the left ventricle (paper
speed was 150 mm/sec); D. His-bundle potential in non-coronary
sinus (paper speed was 150 mm/sec); E. Ventricular fibrillation
occurred when ablating his-bundle potential at Koch triangles
(inlead III, paper speed was 10 mm/sec); F. Right ventricular pacing
after ablating his-bundle(leadIII, VVI/60 bpm, paper speed was 50
mm/sec); G. Biventricular pacing after operation(lead III, VVI/130
bpm, paper speed was 50 mm/sec).
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survived but failed to achieve complete A-V block. The
rest of the 6 subjects in this group were successfully ab-
lated of his-bundle potential and achieved complete A-V
block. The heart rates of the 14 subjects were sustained at
130 bpm (VVI pacing rhythm).
Follow up with electrocardiogram characteristics,
echocardiograph parameters, and BNP levels in the
two groups
The fourteen subjects (eight from the first group, six from
the second group) presented stable VVI pacing rhythm
without complications during the 4 weeks follow-up.
There were no symptoms or body signs indicating heart
failure, such as anorexia, shortness of breath, engorgement
of jugular, etc. There were no significant differences in
weight, breath, echocardiograph parameter, QT interval,
or BNP levels between pre-operation and post-operation
in the subjects, except QRS duration and Tp-Te interval
(Table 2).
Pathological examination
Under the light microscope, the post ablation tissue
showed elliptical coagulation necrosis, which could be eas-
ily distinguished from normal tissue. Myocardial fibrosis,
infiltration of lipocytes, and chronic inflammation of cells
could be clearly seen in the tissue of ablated (Figure 3). As
shown by electron microscope, the ultrastructure of ab-
lated tissue had changed markedly. Under 8000x-
magnification (Figure 4A, C), a longitudinal section of
the cytoplasm was full of aligned myofibrils, I zone, A
zone, H zone, and Z line of myofibrils, making up the
structure of a sarcomere. The cytoplasm was filled with
abundant mitochondria, most of which were round oroval in shape, located between nuclei and myofibrils,
and contained intensive cristae full of inner mitochondrial
space. Under 20000x magnification, many mitochondria
contained incomplete externa and were swollen, showing
reduction and sparseness of cristae (Figure 4B,D). Add-
itionally, some mitochondria vacuolized and disappeared.
Discussion
In 1981,Gonzalez reported ablation of his-bundle potential
at Koch triangles through the femoral vein and complete
atrioventricular (AV) block was induced in 9 of 10 dogs
[2]. After that, we followed this method to build a
complete A-V block animal model. In our research, we
proposed a method of build complete A-V block animal
model - ablation of his-bundle potential through the left
ventricle, meanwhile, we have demostrated that our
method has higher success rates (100% vs 75%), less oc-
currence of malignant arrhythmias(0 cases vs 2 cases),
shorter operation time (107.55 ± 13.26 min vs 151.74 ±
18.32 min, P < 0.05) and X-ray exposure time(10.22 ±
3.67 min vs 15.25 ± 3.70 min,P < 0.05) compared with
traditional method of ablation His-bundle through right
ventricle.
The basis of ablation His-bundle through left ventricle
Anatomically the common stem of the bundle of His is
composed of a non-branching portion and a branching
portion. The former is further divided into penetrating
and non-penetrating parts. The penetrating part of non-
branching portion is enclosed by central fibrous body.
The non-branching portion of the common stem passes
through the right fibrous trigon to reach the top of the
interventricular septum along the posterior and inferior
margin of the membranous portion where it begins to
bifurcate. From this anatomic standpoint, it is conceiv-
able that the his-bundle potential can be recorded when
the catheter electrodes are positioned adjacent to the
membranous septum (right below the aortic valve and
between the noncoronary cusp and right coronary cusp).
In 1975, Ying-shiung reported recorded the electrical
potential of the His-bundle potential from left ventricu-
lar endocardial surface in 28 patients [3]. In their pres-
entation, they utilized a bipolar electrode catheter placed
in the subaortic region (with the tip directed medially
and slightly posteriorly) to record His-bundle potential.
In 1981, Joao Sousa demostrated the feasibility of ablat-
ing AV conduction using radiofrequency energy deliv-
ered in the left ventricle in arrhythmias patients [4]. The
technique was successful in eight patients with refractory
supraventricular tachycardia in whom a conventional ap-
proach with a catheter across the tricuspid valve had failed
to produce AV block. The His bundle potentials recorded
in the left ventricle were generally larger than those re-
corded in the standard position across the tricuspid
Figure 3 HE staining of ablated tissue. A. Light microscope of the first group (×20), ablated tissue presented as coagulation necrosis. B. Light
microscope of the first group (×40), proliferation of the fibroblast cells. C. Light microscope of the second group (×20), infiltration of chronic
inflammatory cells. D. Light microscope of the second group (×40), vacuolization of lipocytes.
Table 2 The changes of ECG characteristics, ECG parameters and BNP levels in the two groups before and after operation
Left ventricle ablation group Right ventricle ablation








Heart rate (bpm) 140 ± 10 130 130 135 ± 7 130 130
Weight (kg) 18.89 ± 1.56 18.39 ± 1.30 19.19 ± 1.45 18.64 ± 1.40 18.15 ± 1.33 19.27 ± 1.19
Respiration rate (bpm) 23.77 ± 4.93 23.67 ± 4.57 23.19 ± 4.18 22.84 ± 4.85 24.35 ± 4.39 23.65 ± 3.88
QRS duration (ms) 70.51 ± 5.20 77.72 ± 4.17** 80.73 ± 4.25* 70.65 ± 6.50 78.50 ± 5.37** 82.81 ± 6.23*
QT intervals (ms) 202.23 ± 18.42 216.31 ± 17.71 216.10 ± 16.73 201.60 ± 13.25 210.54 ± 13.74 211.18 ± 13.65
Tp-Te interval (ms) 59.52 ± 10.87 70.30 ± 8.44 83.81 ± 9.32* 60.23 ± 12.34 67.15 ± 12.68 83.10 ± 8.06*
LAID (mm) 20.31 ± 1.24 20.49 ± 1.62 20.81 ± 1.45 20.15 ± 1.167 20.81 ± 1.167 20.64 ± 1.26
LVEDD (mm) 18.78 ± 1.85 19.40 ± 1.79 19.88 ± 1.42 18.60 ± 1.85 19.03 ± 1.81 19.51 ± 1.15
LVESD (mm) 22.26 ± 2.50 23.93 ± 0.83 22.42 ± 2.69 21.15 ± 1.70 21.98 ± 1.39 22.65 ± 1.48
IVSDD (mm) 5.64 ± 0.64 5.83 ± 0.74 5.10 ± 0.64 5.61 ± 0.88 5.73 ± 0.17 5.75 ± 0.16
IVSSD (mm) 9.71 ± 0.46 9.91 ± 0.35 10.16 ± 0.53 9.72 ± 0.43 9.85 ± 0.31 9.98 ± 0.45
LVEF (%) 67.01 ± 4.06 63.56 ± 3.82 63.60 ± 1.96 65.98 ± 1.39 63.31 ± 1.19 62.65 ± 1.54
FS (%) 35.15 ± 2.02 35.48 ± 2.49 36.65 ± 1.73 34.81 ± 2.30 34.98 ± 2.59 36.31 ± 1.84
BNP (μg/L) 50.09 ± 15.96 52.70 ± 16.51 54.09 ± 14.66 48.18 ± 16.85 50.10 ± 16.26 51.41 ± 15.50
Comparison of the parameters 4-week post operation with those before operation, *P < 0.05;Comparison of the parameters 2-week post operation with those
before operation, **P < 0.05.
LAID: left atrial internal diameter, LVEDD: left ventricle end diastolic diameter, LVESD: left ventricle end systolic diameter, IVSDD: intraventricular septum diastolic
diameter, IVSSD: intraventricular septum systolic diameter, LVEF: Left ventricle ejection fraction, FS = fractional shortening.
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Figure 4 Electron microscope of ablated tissue. A. Electron microscope of the first group (×8000), aligned myofibrils were full of the
cytoplasm, the structure of a sarcomere kept integral; B. Electron microscope of the first group (×20000), abundant mitochondria located between nuclei
and myofibrils, and contained intensive cristae full of inner mitochondrial space; C. Electron microscope of the second group (×8000), the myofibriles and
mitochondria got swollen; D. Electron microscope of the second group (×20000), mitochondria got irregular and the inner cristae became sparse.
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cedure. In 1982, Olga souza reported in six patients in
whom a right-sided of ablation of AV conduction ap-
proach was initially used,but failed [5]. He thought al-
though the His bundle was correctly mapped from the
electrical point of view, contact of the electrode may
have been less than satisfactory. However, a left-sided
approach was used in these patients, resulting in block
in AV conduction. Fewer applications of RF energy
were required from the left side to obtain complete AV
block. He concluded that catheter ablation of His bun-
dle is easier using a left-sided approach than using a
right-sided approach, probably because of a firmer tis-
sue contact. The left-sided approach reduces procedure
and radiation time avoiding complications and recovery
of conduction and may be preferable to conventional
right-sided approach.
All these reserches are performed on patients and
accorded with our study on animal. We firstly demo-
strated that in animal model, ablation his bundle from
left sided way is prior to right side. Ablation his bundle
from left sided way has higher success rates. Further-
more, our method exhibited a less operation and X-ray
exposure time, as well as less malignant arrhythmias.Biventricular pacing and transmural dispersion
repolarization
In our model, successful ablation of His bundle resulted
in a long dependency on biventricular pacemker. We
followed the ECG of the subjects and found that after
4 weeks of pacing relying on biventricular pacemaker,
the QRS duration and Tp-Te interval were apparently
increased compared with preoperation. The Tp-Te inter-
val provides a measure of the transmural dispersion of
repolarization(TDR) [6-10]. Recent studies show a pro-
long Tp-Te has been linked to spontaneous development
of ventricular tachycardia [11]. It is well established that
cardiac resynchronisation therapy (CRT) using biventricu-
lar pacing prolongs survival by its effect on pump failure
[12-15]. Several studies have suggested that CRT suppresss
the incidence of major arrhythmic events, citing reduced
wall stress and decreased repolarization dispersion (as a
result of dual depolarization wavefronts) as potential
mechanism [16-18]. Other studies, however, have demo-
strated a proarrhythmic potential [6,19-22]. Recent reports
suggest that left ventricle epicardial pacing can be proar-
rhythmic, leading to polymorphic ventricular tachycardia
(VT) by reversal of the normal activation sequence, pro-
longation of transmural dispersion of repolarization. LV
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quence from endocardium to epicardium. This reduces
the repolarization time of the already short epicardial
action potentials, thereby increasing repolarization time
differences compared with the longer underlying action
potentials of the midmyocardial and endocardial layers.
Thus, TDR may contribute to ventricular arrhythmias.
In summary, the relationship between the TDR and
biventricular pacing is remain a question. In our study,
there was a significant difference in the Tp-Te intervals
of electrocardiograms between post-operation and pre-
operation which supported the perspective that biven-
tricular pacing increased the transmural dispersion
repolarization.
Disadvantages of our method
Though our method is prior to right-sided method in
many aspects, it still has its inherent disadvantages. Ab-
lation his-bundle from left-sided need the puncture of
femoral artery. In general, an arterial puncture is an in-
nocuous procedure, but occasionally complications may
occur, such as bleeding, aneurysm, A.V. fistula, embolism
and so on. We found that femoral arterial puncture re-
sulted in larger bleeding amount than the femoral venous
puncture in our study (33.31 ± 4.30 vs 9.52 ± 1.28, P <
0.05). However, awareness of the complications of arterial
puncture may help us to avoid their occurrence.
Limitation
In our study, we found that in dogs, ablation his bundle
in the right ventricle was easier triggering malignant ar-
rhythmias than in the left ventricle. However, so far we
just only reported this phenomenon, but could not
explain it. We think it need some further electrophysio-
logical studies. And we will endeavor to explain it in
the future.
Conclusions
Our study shows that the ablation of his-bundle poten-
tial under the aortic sinus of the left ventricular upper
septum is better than the ablation at the right ventricular
Koch triangles in the generation of A-V block model.
The new A-V block model is a reproducible model for
the study of cardiac function.
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